Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Dec 10 executedDec 11, 2025 disclosed
LBRX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
LB PHARMACEUTICALS INC — Employee Stock Option (Right to Buy)
Ticker
LBRX
Shares
195.0K
Price per share
$0
Execution date (reported)
Dec 10, 2025
Owned after transaction
195.0K shares
Days from execution to publication
1
What this establishes
Pai Panandiker Kaya Kamlesh filed this Form 4 reporting a grant or award of LBRX on Dec 10, 2025. It became public on Dec 11, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Commercial Officer
Pai Panandiker Kaya Kamleshcik:0002095250
Issuer
LB PHARMACEUTICALS INCcik:0001691082
Revision history · 0
No field has changed since this record was first ingested.
